Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Olaparib and Temozolomide in Adult Patients With Recurrent/Metastatic Ewing's Sarcoma or Rhabdomyosarcoma Following Failure of Prior Chemotherapy

NCT01858168 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01858168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01858168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Olaparib and Temozolomide in Adult Patients With Recurrent/Metastatic Ewing's Sarcoma or Rhabdomyosarcoma Following Failure of Prior Chemotherapy
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Completed
Start date
July 1, 2013
Completion date
December 12, 2025
Enrollment
49 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

ewing sarcoma, rhabdomyosarcoma